CD4 and melanoma: Collectively, these data suggest that human melanoma cells have an increased expression of IL12RB2 relative to IL12RB1 that is different than observed in immune cells that canonically respond to IL-12, such as NK cells, CD4+ T cells, and CD8+ T cells and qualitatively mirrors what we observed with mouse cell lines.